Form 8-K - Current report:
SEC Accession No. 0001193125-22-025755
Filing Date
2022-02-02
Accepted
2022-02-02 16:31:20
Documents
15
Period of Report
2022-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d255488d8k.htm   iXBRL 8-K 30251
2 EX-10.1 d255488dex101.htm EX-10.1 77059
6 GRAPHIC g255488g0128194620527.jpg GRAPHIC 22753
7 GRAPHIC g255488g0128194621058.jpg GRAPHIC 34753
  Complete submission text file 0001193125-22-025755.txt   334634

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cris-20220127.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20220127_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20220127_pre.xml EX-101.PRE 11707
9 EXTRACTED XBRL INSTANCE DOCUMENT d255488d8k_htm.xml XML 3511
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 22584121
SIC: 2836 Biological Products, (No Diagnostic Substances)